Cyclosporine A and IFNγ licencing enhances human mesenchymal stromal cell potency in a humanised mouse model of acute graft versus host disease
Jennifer M. Corbett(National University of Ireland, Maynooth), Karen English(National University of Ireland, Maynooth), Hazel Dunbar(National University of Ireland, Maynooth), Catherine Flynn(St. James's Hospital), Ian J. Hawthorne(National University of Ireland, Maynooth), Ivan S. Coulter(University College Dublin), Mairéad Ní Chonghaile(St. James's Hospital)
Cited by 19
Related Papers
The Necrobiology of Mesenchymal Stromal Cells Affects Therapeutic Efficacy
|Frontiers in Immunology|2019|100
Human macrophage migration inhibitory factor potentiates mesenchymal stromal cell efficacy in a clinically relevant model of allergic asthma
|Molecular Therapy|2023|22
The ARDS microenvironment enhances MSC-induced repair via VEGF in experimental acute lung inflammation
|Molecular Therapy|2024|18
IFN-γ and PPARδ Influence the Efficacy and Retention of Multipotent Adult Progenitor Cells in Graft vs Host Disease
|Stem Cells Translational Medicine|2021|15